Stock Market

Oncology-focused pharmaceutical company seeks delisting from Berlin exchange

Published in Cancer Weekly, August 17th, 2004

Spectrum Pharmaceuticals, Inc. (SPPI) has sent a formal demand letter to the Berlin Stock Exchange requesting that the exchange delist Spectrum's common stock and any other of the company's securities from the exchange.

Spectrum says it never applied for a listing nor authorize the listing of its shares on the Berlin Exchange. Furthermore, the company did not authorize or direct any German broker to act as a market maker for the company's common stock.

"We do not believe that a listing on the Berlin Exchange provides value to our shareholders and, therefore, we've undertaken this step in an effort to protect the company and our shareholders," stated...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-08-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry